Research Article

The comparison of Body Mass Index (BMI) and Muscle Mass Index (MMI) as a mortality predictor in patients with malignant jaundice at Dr. Sardjito General Hospital, Yogyakarta, Indonesia

Briand Iggreinus Pollah , Adeodatus Yuda Handaya, Agus Barmawi

Briand Iggreinus Pollah
Trainee of Digestive Surgery, Dr. Sardjito General Hospital, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. Email: briandiggrey@gmail.com

Adeodatus Yuda Handaya
Digestive Surgery, Surgery Department, Dr. Sardjito General Hospital, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Agus Barmawi
Digestive Surgery, Surgery Department, Dr. Sardjito General Hospital, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
Online First: August 31, 2021 | Cite this Article
Pollah, B., Handaya, A., Barmawi, A. 2021. The comparison of Body Mass Index (BMI) and Muscle Mass Index (MMI) as a mortality predictor in patients with malignant jaundice at Dr. Sardjito General Hospital, Yogyakarta, Indonesia. Intisari Sains Medis 12(2): 695-699. DOI:10.15562/ism.v12i2.1083


Background: Jaundice is found to be a clinical manifestation of malignancy. Around 70% of all jaundice cases are caused by malignancy. Another complication of malignancy is decreasing the Muscle Mass Index (MMI), also called sarcopenia. MMI in malignant jaundice increases the mortality rate. Body Mass Index (BMI) is describing the nutritional status of a person. Due to malnutrition, morbidity and mortality increase. This study aims to compare the MMI and BMI in patients with malignant jaundice to predict the outcome of mortality

Methods: This study is a retrospective cross sectional non-experimental epidemiologic analysis. Samples were taken from medical reports at Sardjito Hospital from April 2019 - March 2020. A CT scan calculated MMI at the third lumbar vertebrae. BMI was evaluated by body weight (kg) divided by height (m) square (kg/m2). Data were analyzed using SPSS version 20 for Windows.

Results: Most of respondents were males (55.0%), following by age > 50 (62.5%), stage 3 (62.5%), ASA 2 (92.5%), albumin < 3.5 g/dL (82.5%), CA19-9 > 37 U/ml (57.5%), CEA < 5 ng/ml (62.5%), and total bilirubin > 1.5 mg/dL (90.0%), normal BMI (62.5%), survive (77.5%), and low MMI (72.5%). There was no significant relationship between MMI (OR: 5.71; 95%CI: 0.60-134.12) and BMI (OR: 0.15; 95%CI: 0.02-1.34) to the mortality risk (p>0.05).

Conclusion: MMI had a higher incidence of mortality compared to BMI in malignant jaundice. However, there was no significant relationship between MMI and BMI to predict mortality.

References

Chindapasirt J. Sarcopenia in Cancer Patients. Asian Pac J Cancer Prev. 2015;16(18):8075-8077.

Oto BT, Fauzi A, Syam AF, Simadibrata M, Abdullah M, Makmun D, et al. Identification and stenting malignant obstruction jaundice: determining the success rate of ERCP. Indonesia J Gastroenterol Hepatol Dig Endosc. 2012;13(1):19-22.

Garcea G, Ngu W, Neal CP, Dennison AR, Berry DP. Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB (Oxford). 2011;13(6):426-430.

Ohashi K, Ishikawa T, Hoshi A, Suzuki M, Mitobe Y, Yamada E, et al. Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease. J Clin Med Res. 2018;10(12):920-927.

Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis. 2015;17(11):O256-64.

Moghimi M, Marashi SA, Salehian MT, Sheikhvatan M. Obstructive jaundice in Iran: factors affecting early outcome. Hepatobiliary Pancreat Dis Int. 2008;7(5):515-519.

Yusuf F, Innayah MR, Maghfirah D, Azzaki, Riswan M. Obstructive jaundice as manifestation of relapsing Hodgkin’s Lymphoma: the success of chemotherapy (case report). Bali Medical Journal. 2020;9(1):115-120.

Qiu YD, Bai JL, Xu FG, Ding YT. Effect of preoperative biliary drainage on malignant obstructive jaundice: a meta-analysis. World J Gastroenterol. 2011;17(3):391-396.

Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol. 2012;3(2):105-119.

Myatra S, Divatia JV, Jibhkate B, Barreto GS, Shrikhande SV. Preoperative assessment and optimization in periampullary and pancreatic cancer. Indian J Cancer. 2011;48(1):86-93.

Sut M, Kennedy R, McNamee J, Collins A, Clements B. Long-term results of percutaneous transhepatic cholangiographic drainage for palliation of malignant biliary obstruction. J Palliat Med. 2010;13(11):1311-1313.

Fernández-Ruiz M, Guerra-Vales JM, Colina-Ruizdelgado F. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol. 2009;15(42):5279-5286.

Jeurnink SM, Steyerberg EW, Vleggaar FP, van Eijck CH, van Hooft JE, Schwartz MP, et al. Predictors of survival in patients with malignant gastric outlet obstruction: a patient-oriented decision approach for palliative treatment. Dig Liver Dis. 2011;43(7):548-52.

Zhou G, Bao H, Zeng Q, Hu W, Zhang Q. Sarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study. Int J Clin Exp Med. 2015;8(10):18245-18254.

Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95-101.

Boulay BR, Birg A. Malignant biliary obstruction: From palliation to treatment. World J Gastrointest Oncol. 2016;8(6):498-508.

Tran TB, Norton JA, Ethun CG, Pawlik TM, Buettner S, Schmidt C, et al. Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable? J Gastrointest Surg. 2017;21(8):1245-1253.

Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-298.

Yoon SB, Choi MH, Song M, Lee JH, Lee IS, Lee MA, Hong TH, Jung ES, Choi MG. Impact of preoperative body compositions on survival following resection of biliary tract cancer. J Cachexia Sarcopenia Muscle. 2019;10(4):794-802.

Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187-1196.

Takenami T, Maeda S, Karasawa H, Suzuki T, Furukawa T, Morikawa T, et al. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis. BMC Cancer. 2019;19(1):318.


No Supplementary Material available for this article.
Article Views      : 67
PDF Downloads : 37